secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001649094-25-000102
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte signs 15-year manufacturing deal with Thermo Fisher's Patheon
---------------------------------------------------------------------

- Agreement covers formulation, fill, finish, testing at Patheon's Greenville, NC facility.
- Binding minimum purchase commitments; termination fee in mid-eight-figures for convenience.
- Initial 15-year term with auto-renewal; includes tech transfer and capex reimbursement.
- Customary termination rights for cause, regulatory breach, or insolvency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/0001649094-25-000102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/pcvx-20250924.htm
  HTML page:      https://secwatch.observer/filing/0001649094-25-000102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer